Researchers identify what drives PARP inhibitor resistance in advanced breast cancer 08 May 2024 Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease. Find out more Show/Hide
Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells 16 Oct 2023 Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new research published in Nature. Find out more Show/Hide
New AI drug discovery collaboration aims to design new precision cancer drugs 13 Jul 2023 Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future. Find out more Show/Hide
Liquid biopsies one step closer to entering the clinic to help guide breast cancer treatment 01 Nov 2021
The Princess Royal officially opens pioneering centre for 'Darwinian' cancer drug discovery 08 Oct 2021